FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109279403> ?p ?o ?g. }

• W2109279403 endingPage "499" @default.
• W2109279403 startingPage "491" @default.
• W2109279403 abstract "In the Non-Hodgkin's Lymphoma-Berlin-Frankfurt-Munster (NHL-BFM) 95 trial, we tested, against the historical control of the combined trials NHL-BFM90 and NHL-BFM86, whether prophylactic cranial radiotherapy (PCRT) can be omitted for CNS-negative patients with stage III or IV lymphoblastic lymphoma (LBL) with sufficient early response.Apart from the removal of PCRT in NHL-BFM95, the chemotherapy of the three trials was identical except for the amount of l-asparaginase and daunorubicin during induction. The therapy in NHL-BFM95 was accepted to be noninferior when compared with trials NHL-BFM90/86 if the lower limit of the one-sided 95% CI for the difference in the 2-year probability of event-free-survival (pEFS) between target patients of NHL-BFM95 and the historical controls of NHL-BFM90/86 did not exceed -14%. The target patient group consisted of stage III and IV patients who were CNS negative and responded well to induction therapy.The number of target patients was 156 in NHL-BFM95 (median age, 8.6 years; range, 0.2 to 19.5 years) and 163 in NHL-BFM90/86 (median age, 8.4 years; range, 0.6 to 16.6 years). For the target group, the pEFS rates at 2 and 5 years were 86% +/- 3% and 82% +/- 3%, respectively, in NHL-BFM95 (median follow-up time, 5.1 years; range, 2.1 to 9.1 years) compared with 91% +/- 2% and 88% +/- 3%, respectively in NHL-BFM90/86 (median follow-up time, 10.7 years; range, 5 to 15.4 years). The lower limit of the one-sided 95% CI for the difference in pEFS was -11% at 2 years and -13% at 5 years. In NHL-BFM95, one isolated and two combined CNS relapses occurred compared with one combined CNS relapse in NHL-BFM90/86. Five-year disease-free-survival rate was 88% +/- 3% in NHL-BFM95 compared with 91% +/- 2% in NHL-BFM90/86.For CNS-negative patients with stage III or IV LBL and sufficient response to induction therapy, treatment without PCRT may be noninferior to treatment including PCRT." @default.
• W2109279403 created "2016-06-24" @default.
• W2109279403 creator A5007763268 @default.
• W2109279403 creator A5009928308 @default.
• W2109279403 creator A5014093899 @default.
• W2109279403 creator A5020812442 @default.
• W2109279403 creator A5024966176 @default.
• W2109279403 creator A5025613660 @default.
• W2109279403 creator A5027750890 @default.
• W2109279403 creator A5037725633 @default.
• W2109279403 creator A5042744031 @default.
• W2109279403 creator A5051824759 @default.
• W2109279403 creator A5053493422 @default.
• W2109279403 creator A5055603770 @default.
• W2109279403 creator A5082583670 @default.
• W2109279403 creator A5089049333 @default.
• W2109279403 date "2006-01-20" @default.
• W2109279403 modified "2023-10-01" @default.
• W2109279403 title "Impact of Cranial Radiotherapy on Central Nervous System Prophylaxis in Children and Adolescents With Central Nervous System–Negative Stage III or IV Lymphoblastic Lymphoma" @default.
• W2109279403 cites W1672417844 @default.
• W2109279403 cites W1783869668 @default.
• W2109279403 cites W1868055647 @default.
• W2109279403 cites W1877251196 @default.
• W2109279403 cites W1905316660 @default.
• W2109279403 cites W1914340996 @default.
• W2109279403 cites W1934853243 @default.
• W2109279403 cites W1954501079 @default.
• W2109279403 cites W1967362639 @default.
• W2109279403 cites W1968274099 @default.
• W2109279403 cites W2000332333 @default.
• W2109279403 cites W2002297908 @default.
• W2109279403 cites W2005688611 @default.
• W2109279403 cites W2014508197 @default.
• W2109279403 cites W2022874285 @default.
• W2109279403 cites W2034320561 @default.
• W2109279403 cites W2057697502 @default.
• W2109279403 cites W2057730383 @default.
• W2109279403 cites W2068619849 @default.
• W2109279403 cites W2068835290 @default.
• W2109279403 cites W2075958495 @default.
• W2109279403 cites W2080828049 @default.
• W2109279403 cites W2093958150 @default.
• W2109279403 cites W2095669126 @default.
• W2109279403 cites W2109279774 @default.
• W2109279403 cites W2113911127 @default.
• W2109279403 cites W2118618980 @default.
• W2109279403 cites W2124303054 @default.
• W2109279403 cites W2124999940 @default.
• W2109279403 cites W2126142122 @default.
• W2109279403 cites W2129214379 @default.
• W2109279403 cites W2147996630 @default.
• W2109279403 cites W2154162565 @default.
• W2109279403 cites W2170012309 @default.
• W2109279403 cites W2179376787 @default.
• W2109279403 cites W2310146029 @default.
• W2109279403 cites W2400758460 @default.
• W2109279403 cites W30310674 @default.
• W2109279403 cites W4243369338 @default.
• W2109279403 cites W4293241248 @default.
• W2109279403 doi "https://doi.org/10.1200/jco.2005.02.2707" @default.
• W2109279403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16421426" @default.
• W2109279403 hasPublicationYear "2006" @default.
• W2109279403 type Work @default.
• W2109279403 sameAs 2109279403 @default.
• W2109279403 citedByCount "135" @default.
• W2109279403 countsByYear W21092794032012 @default.
• W2109279403 countsByYear W21092794032013 @default.
• W2109279403 countsByYear W21092794032014 @default.
• W2109279403 countsByYear W21092794032015 @default.
• W2109279403 countsByYear W21092794032016 @default.
• W2109279403 countsByYear W21092794032017 @default.
• W2109279403 countsByYear W21092794032018 @default.
• W2109279403 countsByYear W21092794032019 @default.
• W2109279403 countsByYear W21092794032020 @default.
• W2109279403 countsByYear W21092794032021 @default.
• W2109279403 countsByYear W21092794032022 @default.
• W2109279403 countsByYear W21092794032023 @default.
• W2109279403 crossrefType "journal-article" @default.
• W2109279403 hasAuthorship W2109279403A5007763268 @default.
• W2109279403 hasAuthorship W2109279403A5009928308 @default.
• W2109279403 hasAuthorship W2109279403A5014093899 @default.
• W2109279403 hasAuthorship W2109279403A5020812442 @default.
• W2109279403 hasAuthorship W2109279403A5024966176 @default.
• W2109279403 hasAuthorship W2109279403A5025613660 @default.
• W2109279403 hasAuthorship W2109279403A5027750890 @default.
• W2109279403 hasAuthorship W2109279403A5037725633 @default.
• W2109279403 hasAuthorship W2109279403A5042744031 @default.
• W2109279403 hasAuthorship W2109279403A5051824759 @default.
• W2109279403 hasAuthorship W2109279403A5053493422 @default.
• W2109279403 hasAuthorship W2109279403A5055603770 @default.
• W2109279403 hasAuthorship W2109279403A5082583670 @default.
• W2109279403 hasAuthorship W2109279403A5089049333 @default.
• W2109279403 hasBestOaLocation W21092794031 @default.
• W2109279403 hasConcept C126322002 @default.
• W2109279403 hasConcept C141071460 @default.
• W2109279403 hasConcept C146357865 @default.
• W2109279403 hasConcept C151730666 @default.
• W2109279403 hasConcept C203014093 @default.

• next